LONDON (Reuters) - The U.S. launch of two generic forms of Wyeth's ulcer drug Protonix will inevitably impact volume demand and increase pressure on prices for rival branded medicines, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results